Skip to content
healthcare.dev

RISEDRONATE SODIUM

NDC 63304-440, RISEDRONATE SODIUM, tablet, delayed release, from Sun Pharmaceutical Industires Inc..

Product NDC
63304-440
Status
Listed
Labeler
Sun Pharmaceutical Industires Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203925
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63304-440 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
63304-440-09633040440091 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d9e520b-2fa6-4603-b397-f0fc24fae775

Use it

Look up 63304-440 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63304-440 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63304-440. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.